Neuland Laboratories' Stock Reaches All-Time High, Outperforms Sector and Sensex

Oct 12 2024 09:20 AM IST
share
Share Via
Neuland Laboratories, a midcap pharmaceutical company, has been making headlines in the stock market with its impressive performance. On October 12, 2024, its stock price reached an all-time high of Rs. 14500.35, outperforming the sector by 13.01%. With a remarkable 25.43% increase in value in the past four days, the company's consistent growth and strong financial performance have caught the attention of investors.

Neuland Laboratories, a midcap pharmaceutical company, has been making waves in the stock market with its impressive performance. On October 12, 2024, the company's stock price reached an all-time high of Rs. 14500.35, breaking its previous 52-week high. This has caught the attention of investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock.

In today's trading session, Neuland Laboratories outperformed the sector by 13.01%, showcasing its strong growth potential. The stock has been on a winning streak for the past four days, with a remarkable 25.43% increase in its value. This is a clear indication of the company's consistent growth and strong financial performance.

Neuland Laboratories' stock also touched an intraday high of Rs. 14500.35, which is a significant 16% increase from its previous closing price. This further solidifies the company's position as a top performer in the market.

Moreover, Neuland Laboratories is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bullish trend for the stock. This is a positive sign for investors, as it shows the company's stock is on an upward trajectory.

In the past year, Neuland Laboratories has outperformed the Sensex by a staggering 274.28%, while the Sensex has only seen a 22.43% increase. This showcases the company's strong growth potential and its ability to deliver impressive returns to its investors.

With its consistent growth, strong financial performance, and bullish trend, Neuland Laboratories is definitely a stock to watch out for in the pharmaceutical industry. Investors can expect to see more positive developments from this midcap company in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News